Pfenex Inc. - Investors http://pfenex.investorroom.com/ Pfenex Set to Join Russell 2000® Index http://pfenex.investorroom.com/news-releases?item=121 Fri, 22 Jun 2018 17:16:00 -0400 http://pfenex.investorroom.com/news-releases?item=121 Pfenex to Present at the JMP Securities 2018 Life Science Conference http://pfenex.investorroom.com/news-releases?item=120 Thu, 14 Jun 2018 16:15:00 -0400 http://pfenex.investorroom.com/news-releases?item=120 Pfenex and Alvogen Enter into U.S. Agreement for Commercialization of PF708, a Therapeutic Equivalent Candidate to Forteo® http://pfenex.investorroom.com/news-releases?item=119 Mon, 11 Jun 2018 16:05:00 -0400 http://pfenex.investorroom.com/news-releases?item=119 Pfenex to Present at the Jefferies 2018 Global Healthcare Conference http://pfenex.investorroom.com/news-releases?item=118 Wed, 30 May 2018 09:25:00 -0400 http://pfenex.investorroom.com/news-releases?item=118 Pfenex Announces Closing of Public Offering of 7,820,000 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares http://pfenex.investorroom.com/news-releases?item=117 Tue, 29 May 2018 10:13:00 -0400 http://pfenex.investorroom.com/news-releases?item=117